Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.45 |
| ▸ | CCR5 | P51681 | 3/20 | 0.45 |
| ▸ | CCR8 | P51685 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.38 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | CDK9 | P50750 | 1/20 | 0.36 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.36 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.36 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.36 |
| ▸ | ATR | Q13535 | 6/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13385159 | 0.83 | SLC40A1 (0.35) | CCR1CCR5CCR8MEN1POLB | |
| SCHEMBL30614513 | 0.81 | MEN1 (0.40) | MEN1POLBKMT2ACDK2CDK5 | |
| SCHEMBL13757501 | 0.81 | NR4A2 (0.51) | MEN1POLBKMT2ACDK9CDK5 | |
| SCHEMBL13409381 | 0.81 | MEN1 (0.40) | MEN1POLBKMT2ACDK2CDK5 | |
| SCHEMBL13409380 | 0.78 | NCF1 (0.46) | MEN1POLBKMT2ACDK2CDK5 | |
| Hydrochloric Acid SCHEMBL5931133 | 0.78 | ATR (0.33) | CCR1CCR5CCR8MEN1POLB | |
| SCHEMBL185654 | 0.76 | CCR1 (0.50) | CCR1CCR5CCR8MEN1KMT2A | |
| SCHEMBL12282776 | 0.75 | MAPT (0.47) | MEN1KMT2AIRAK4MAPTNPC1 | |
| SCHEMBL12180599 | 0.74 | MEN1 (0.50) | CCR1CCR5CCR8MEN1POLB | |
| SCHEMBL27399036 | 0.73 | L3MBTL1 (0.52) | CCR1CCR5CCR8MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1546168-A4 | PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT | PURDUE RESEARCH FOUNDATION (US) | 2008-03-12 | — | — | EP | disclosed |
| US-20060111335-A1 | Photoactivated anti-viral and anti-cancer agent | PURDUE RESEARCH FOUNDATION | 2006-05-25 | — | — | US | disclosed |
| EP-1546168-A2 | PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT | PURDUE RESEARCH FOUNDATION (US) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004012667-A2 | PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT | PURDUE RESEARCH FOUNDATION (US) | 2004-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111335-A1 | Photoactivated anti-viral and anti-cancer agent | TP53, POLI, POLK | CCR1 4643/4885CCR5 4137/4885CCR8 4400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.